EcoDrugPlus

Ensembl ID : ENSBBBG00000017434
Gene Symbol: -
Cross references: -
79 Possible Orthologues:

Ensembl ID : ENSBBBG00000017102
Gene Symbol: -
Cross references: -
79 Possible Orthologues:

Ensembl ID : ENSBBBG00000016535
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSBBBG00000022134
Gene Symbol: -
Cross references: -
75 Possible Orthologues:

Ensembl ID : ENSBBBG00000021781
Gene Symbol: -
Cross references: -
187 Possible Orthologues:

Ensembl ID : ENSBBBG00000018228
Gene Symbol: -
Cross references: -
108 Possible Orthologues:

Ensembl ID : ENSBBBG00000022980
Gene Symbol: -
Cross references: -
220 Possible Orthologues:

Ensembl ID : ENSBBBG00000010487
Gene Symbol: -
Cross references: -
72 Possible Orthologues:

Ensembl ID : ENSBBBG00000003487
Gene Symbol: -
Cross references: -
72 Possible Orthologues:

Ensembl ID : ENSBBBG00000020420
Gene Symbol: -
Cross references: -
296 Possible Orthologues:

Ensembl ID : ENSBBBG00000020636
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSBBBG00000022523
Gene Symbol: -
Cross references: -
144 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).